{"id":"https://openalex.org/W4241369424","doi":"https://doi.org/10.1021/acs.oprd.0c00036","title":"Green Chemistry Articles of Interest to the Pharmaceutical Industry","display_name":"Green Chemistry Articles of Interest to the Pharmaceutical Industry","publication_year":2020,"publication_date":"2020-03-02","ids":{"openalex":"https://openalex.org/W4241369424","doi":"https://doi.org/10.1021/acs.oprd.0c00036"},"language":"en","primary_location":{"id":"doi:10.1021/acs.oprd.0c00036","doi":"https://doi.org/10.1021/acs.oprd.0c00036","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.oprd.0c00036","pdf_url":null,"source":{"id":"https://openalex.org/S107255770","display_name":"Organic Process Research & Development","issn_l":"1083-6160","issn":["1083-6160","1520-586X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Organic Process Research & Development","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024354698","display_name":"M. Braun","orcid":"https://orcid.org/0000-0002-5644-3711","observed_orcids":["https://orcid.org/0000-0002-5644-3711","https://orcid.org/0000-0002-0837-9719"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marie-Gabrielle Braun","raw_affiliation_strings":["Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037369709","display_name":"Louis J. Diorazio","orcid":"https://orcid.org/0000-0001-8017-9167","observed_orcids":["https://orcid.org/0000-0001-8017-9167"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Louis Diorazio","raw_affiliation_strings":["AstraZeneca, Macclesfield SK10 2NA, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Macclesfield SK10 2NA, U.K","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069254574","display_name":"Kenneth J. Fraunhoffer","orcid":"https://orcid.org/0000-0002-1771-3416","observed_orcids":["https://orcid.org/0000-0002-1771-3416"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Fraunhoffer","raw_affiliation_strings":["Bristol-Myers Squibb, Co., One Squibb Drive, New Brunswick, New Jersey 08903, United States"],"raw_orcid":"https://orcid.org/0000-0002-1771-3416","affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Co., One Squibb Drive, New Brunswick, New Jersey 08903, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028528533","display_name":"John D. Hayler","orcid":"https://orcid.org/0000-0003-3685-3139","observed_orcids":["https://orcid.org/0000-0003-3685-3139"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John Hayler","raw_affiliation_strings":["GlaxoSmithKline, Stevenage, Hertfordshire SG1 2NY, U.K"],"raw_orcid":"https://orcid.org/0000-0003-3685-3139","affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Stevenage, Hertfordshire SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084357536","display_name":"Matthew Hickey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Matthew Hickey","raw_affiliation_strings":["Bristol-Myers Squibb, Co., One Squibb Drive, New Brunswick, New Jersey 08903, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Co., One Squibb Drive, New Brunswick, New Jersey 08903, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040446294","display_name":"Jonathan Latham","orcid":"https://orcid.org/0000-0002-5906-9024","observed_orcids":["https://orcid.org/0000-0002-5906-9024"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jonathan Latham","raw_affiliation_strings":["GlaxoSmithKline, Stevenage, Hertfordshire SG1 2NY, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Stevenage, Hertfordshire SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052201878","display_name":"Lucie E. Lovelle","orcid":"https://orcid.org/0000-0002-8927-7270","observed_orcids":["https://orcid.org/0000-0002-8927-7270","https://orcid.org/0000-0002-3373-0523"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Lucie E. Lovelle","raw_affiliation_strings":["Novartis Pharma AG, Forum 1, Novartis Campus, 4056 Basel, Switzerland"],"raw_orcid":"https://orcid.org/0000-0002-8927-7270","affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Forum 1, Novartis Campus, 4056 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113779177","display_name":"Mark D. McLaws","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark McLaws","raw_affiliation_strings":["Asymchem Inc., 600 Airport Boulevard, Suite 1000, Morrisville, North Carolina 27560, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asymchem Inc., 600 Airport Boulevard, Suite 1000, Morrisville, North Carolina 27560, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066345448","display_name":"Andrew T. Parsons","orcid":"https://orcid.org/0000-0002-0320-0919","observed_orcids":["https://orcid.org/0000-0002-0320-0919"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew T. Parsons","raw_affiliation_strings":["Amgen, 360 Binney Street, Cambridge, Massachusetts 02139, United States"],"raw_orcid":"https://orcid.org/0000-0002-0320-0919","affiliations":[{"raw_affiliation_string":"Amgen, 360 Binney Street, Cambridge, Massachusetts 02139, United States","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006108649","display_name":"Paul Richardson","orcid":"https://orcid.org/0000-0002-3700-8749","observed_orcids":["https://orcid.org/0000-0002-3700-8749"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Richardson","raw_affiliation_strings":["Pfizer Global Research and Development, 10578 Science Center Drive, La Jolla, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research and Development, 10578 Science Center Drive, La Jolla, California 92121, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060598645","display_name":"Gheorghe\u2010Doru Roiban","orcid":"https://orcid.org/0000-0002-5006-3240","observed_orcids":["https://orcid.org/0000-0002-5006-3240"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gheorghe-Doru Roiban","raw_affiliation_strings":["GlaxoSmithKline, Stevenage, Hertfordshire SG1 2NY, U.K"],"raw_orcid":"https://orcid.org/0000-0002-5006-3240","affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Stevenage, Hertfordshire SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078981517","display_name":"Philipp C. Roosen","orcid":"https://orcid.org/0009-0004-4565-6975","observed_orcids":["https://orcid.org/0009-0004-4565-6975"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philipp C. Roosen","raw_affiliation_strings":["Amgen, Thousand Oaks, California 91320, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Thousand Oaks, California 91320, United States","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055300360","display_name":"Alan Steven","orcid":"https://orcid.org/0000-0002-0134-0918","observed_orcids":["https://orcid.org/0000-0002-0134-0918"]},"institutions":[{"id":"https://openalex.org/I4210120285","display_name":"CatScI (United Kingdom)","ror":"https://ror.org/01ttqmm87","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210120285"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Alan Steven","raw_affiliation_strings":["CatSci Ltd, CBTC2, Capital Business Park, Cardiff CF3 2PX, U.K"],"raw_orcid":"https://orcid.org/0000-0002-0134-0918","affiliations":[{"raw_affiliation_string":"CatSci Ltd, CBTC2, Capital Business Park, Cardiff CF3 2PX, U.K","institution_ids":["https://openalex.org/I4210120285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061884583","display_name":"Jack A. Terrett","orcid":"https://orcid.org/0000-0001-8777-046X","observed_orcids":["https://orcid.org/0000-0001-8777-046X"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jack A. Terrett","raw_affiliation_strings":["Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States"],"raw_orcid":"https://orcid.org/0000-0001-8777-046X","affiliations":[{"raw_affiliation_string":"Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034896547","display_name":"Timothy White","orcid":"https://orcid.org/0000-0003-3101-1418","observed_orcids":["https://orcid.org/0000-0003-3101-1418"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy White","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana 46285, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana 46285, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113870712","display_name":"Jingjun Yin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jingjun Yin","raw_affiliation_strings":["Merck and Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck and Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5055300360","https://openalex.org/A5084357536"],"corresponding_institution_ids":["https://openalex.org/I4210091812","https://openalex.org/I4210120285"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":0.4627,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.55688028,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"24","issue":"3","first_page":"334","last_page":"346"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13180","display_name":"Chemistry and Chemical Engineering","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2304","display_name":"Environmental Chemistry"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T13180","display_name":"Chemistry and Chemical Engineering","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2304","display_name":"Environmental Chemistry"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10880","display_name":"Environmental Sustainability in Business","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1406","display_name":"Marketing"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11407","display_name":"Innovative Microfluidic and Catalytic Techniques Innovation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/green-chemistry","display_name":"green chemistry","score":0.996999979019165},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.8870000243186951},{"id":"https://openalex.org/keywords/sustainable-chemical-synthesis","display_name":"sustainable chemical synthesis","score":0.4410000145435333},{"id":"https://openalex.org/keywords/pharmaceutical-manufacturing","display_name":"pharmaceutical manufacturing","score":0.3880000114440918},{"id":"https://openalex.org/keywords/pharmaceutical-process-development","display_name":"pharmaceutical process development","score":0.3889999985694885},{"id":"https://openalex.org/keywords/environmental-impact-of-pharmaceuticals","display_name":"environmental impact of pharmaceuticals","score":0.47099998593330383},{"id":"https://openalex.org/keywords/chemical-waste-reduction","display_name":"chemical waste reduction","score":0.3720000088214874},{"id":"https://openalex.org/keywords/biocatalysis","display_name":"biocatalysis","score":0.5899999737739563},{"id":"https://openalex.org/keywords/atom-economy","display_name":"atom economy","score":0.45100000500679016},{"id":"https://openalex.org/keywords/solvent-reduction","display_name":"solvent reduction","score":0.30399999022483826},{"id":"https://openalex.org/keywords/carbon-footprint-reduction","display_name":"carbon footprint reduction","score":0.42500001192092896},{"id":"https://openalex.org/keywords/green-solvents","display_name":"green solvents","score":0.4050000011920929},{"id":"https://openalex.org/keywords/green-reagents","display_name":"green reagents","score":0.34200000762939453},{"id":"https://openalex.org/keywords/green-analytical-chemistry","display_name":"green analytical chemistry","score":0.42399999499320984},{"id":"https://openalex.org/keywords/green-analytical-method","display_name":"green analytical method","score":0.3319999873638153}],"concepts":[{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.5609407424926758},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5487266182899475},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.3938072621822357},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.389819860458374},{"id":"https://openalex.org/C126348684","wikidata":"https://www.wikidata.org/wiki/Q3456979","display_name":"Polymer science","level":1,"score":0.3505312502384186},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.24666818976402283},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.15494340658187866},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.0792270302772522},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.07636180520057678}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1021/acs.oprd.0c00036","doi":"https://doi.org/10.1021/acs.oprd.0c00036","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.oprd.0c00036","pdf_url":null,"source":{"id":"https://openalex.org/S107255770","display_name":"Organic Process Research & Development","issn_l":"1083-6160","issn":["1083-6160","1520-586X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Organic Process Research & Development","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"sustainable_development_goals_aurora":[{"display_name":"Industry, innovation and infrastructure","id":"https://metadata.un.org/sdg/9","score":0.4300000071525574}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2324080322","https://openalex.org/W3143761869","https://openalex.org/W7000727247","https://openalex.org/W2947428935","https://openalex.org/W6977326984","https://openalex.org/W2914062418","https://openalex.org/W2949132874","https://openalex.org/W6941320563","https://openalex.org/W1976085443","https://openalex.org/W7163889994"],"abstract_inverted_index":{"ADVERTISEMENT":[0],"RETURN":[1],"TO":[2],"ISSUEPREVGreen":[3],"Chemistry":[4,6,8],"High...Green":[5],"HighlightsNEXTGreen":[7],"Articles":[9],"of":[10,310,345,371],"Interest":[11],"to":[12,332,337],"the":[13,307,338,343,372,383,396,399,404,411,417],"Pharmaceutical":[14],"IndustryMarie-Gabrielle":[15],"BraunMarie-Gabrielle":[16],"BraunGenentech,":[17],"Inc.,":[18,123,223,258],"1":[19,224],"DNA":[20,225],"Way,":[21,226],"South":[22,227],"San":[23,228],"Francisco,":[24,229],"California":[25,168,193,230],"94080,":[26,231],"United":[27,55,84,133,149,170,195,232,247,266],"StatesMore":[28,56,134,150,171,196,233,248,267],"by":[29,39,57,68,88,99,116,135,151,172,183,197,215,234,249,268,352],"Marie-Gabrielle":[30],"Braun,":[31],"Louis":[32,40],"DiorazioLouis":[33],"DiorazioAstraZeneca,":[34],"Macclesfield":[35],"SK10":[36],"2NA,":[37],"U.K.More":[38,67,98,182],"Diorazio,":[41],"Kenneth":[42,58],"FraunhofferKenneth":[43],"FraunhofferBristol-Myers":[44],"Squibb,":[45,74],"Co.,":[46,75,257],"One":[47,76],"Squibb":[48,77],"Drive,":[49,78,165],"New":[50,52,79,81,263],"Brunswick,":[51,80],"Jersey":[53,82,264],"08903,":[54,83],"Fraunhofferhttp://orcid.org/0000-0002-1771-3416,":[59],"John":[60,69],"HaylerJohn":[61],"HaylerGlaxoSmithKline,":[62],"Stevenage,":[63,94,178],"Hertfordshire":[64,95,179],"SG1":[65,96,180],"2NY,":[66,97,181],"Haylerhttp://orcid.org/0000-0003-3685-3139,":[70],"Matthew":[71,89],"Hickey*Matthew":[72],"HickeyBristol-Myers":[73],"States*E-mail:":[85],"[email":[86,213],"protected]More":[87,214],"Hickey,":[90],"Jonathan":[91,100],"LathamJonathan":[92],"LathamGlaxoSmithKline,":[93],"Latham,":[101],"Lucie":[102,117],"E.":[103,105,118],"LovelleLucie":[104],"LovelleNovartis":[106],"Pharma":[107],"AG,":[108],"Forum":[109],"1,":[110],"Novartis":[111],"Campus,":[112],"4056":[113],"Basel,":[114],"SwitzerlandMore":[115],"Lovellehttp://orcid.org/0000-0002-8927-7270,":[119],"Mark":[120,136],"McLawsMark":[121],"McLawsAsymchem":[122],"600":[124],"Airport":[125],"Boulevard,":[126],"Suite":[127],"1000,":[128],"Morrisville,":[129],"North":[130],"Carolina":[131],"27560,":[132],"McLaws,":[137],"Andrew":[138,152],"T.":[139,141,153],"ParsonsAndrew":[140],"ParsonsAmgen,":[142],"360":[143],"Binney":[144],"Street,":[145],"Cambridge,":[146],"Massachusetts":[147],"02139,":[148],"Parsonshttp://orcid.org/0000-0002-0320-0919,":[154],"Paul":[155,173],"RichardsonPaul":[156],"RichardsonPfizer":[157],"Global":[158],"Research":[159],"and":[160,242,252,256,320,325,354,398,415,431,433],"Development,":[161],"10578":[162],"Science":[163],"Center":[164],"La":[166],"Jolla,":[167],"92121,":[169],"Richardson,":[174],"Gheorghe-Doru":[175,184],"RoibanGheorghe-Doru":[176],"RoibanGlaxoSmithKline,":[177],"Roibanhttp://orcid.org/0000-0002-5006-3240,":[185],"Philipp":[186,198],"C.":[187,189,199],"RoosenPhilipp":[188],"RoosenAmgen,":[190],"Thousand":[191],"Oaks,":[192],"91320,":[194],"Roosen,":[200],"Alan":[201,216],"Steven*Alan":[202],"StevenCatSci":[203],"Ltd,":[204],"CBTC2,":[205],"Capital":[206],"Business":[207],"Park,":[208],"Cardiff":[209],"CF3":[210],"2PX,":[211],"U.K.*E-mail:":[212],"Stevenhttp://orcid.org/0000-0002-0134-0918,":[217],"Jack":[218,235],"A.":[219,221,236],"TerrettJack":[220],"TerrettGenentech,":[222],"Terretthttp://orcid.org/0000-0001-8777-046X,":[237],"Timothy":[238,250],"WhiteTimothy":[239],"WhiteEli":[240],"Lilly":[241],"Company,":[243],"Indianapolis,":[244],"Indiana":[245],"46285,":[246],"White,":[251],"Jingjun":[253,269],"YinJingjun":[254],"YinMerck":[255],"P.O.":[259],"Box":[260],"2000,":[261],"Rahway,":[262],"07065,":[265],"YinCite":[270],"this:":[271],"Org.":[272],"Process":[273],"Res.":[274],"Dev.":[275],"2020,":[276],"24,":[277],"3,":[278],"334\u2013346Publication":[279],"Date":[280],"(Web):March":[281],"2,":[282],"2020Publication":[283],"History":[284],"Published":[285],"online2":[286],"March":[287,291],"2020Published":[288],"inissue":[289],"20":[290],"2020https://pubs.acs.org/doi/10.1021/acs.oprd.0c00036https://doi.org/10.1021/acs.oprd.0c00036research-articleACS":[292],"PublicationsCopyright":[293],"\u00a9":[294],"2020":[295],"American":[296],"Chemical":[297],"SocietyRequest":[298],"reuse":[299],"permissionsArticle":[300],"Views2773Altmetric-Citations6LEARN":[301],"ABOUT":[302],"THESE":[303],"METRICSArticle":[304],"Views":[305],"are":[306,329,342],"COUNTER-compliant":[308],"sum":[309],"full":[311],"text":[312],"article":[313,377],"downloads":[314],"since":[315],"November":[316],"2008":[317],"(both":[318],"PDF":[319],"HTML)":[321],"across":[322],"all":[323],"institutions":[324],"individuals.":[326],"These":[327],"metrics":[328],"regularly":[330],"updated":[331,355],"reflect":[333],"usage":[334],"leading":[335],"up":[336],"last":[339],"few":[340],"days.Citations":[341],"number":[344],"other":[346],"articles":[347],"citing":[348],"this":[349],"article,":[350],"calculated":[351],"Crossref":[353,361],"daily.":[356],"Find":[357,407],"more":[358,408],"information":[359,409],"about":[360,395],"citation":[362],"counts.The":[363],"Altmetric":[364,412],"Attention":[365,413],"Score":[366,414],"is":[367,419],"a":[368,375,388],"quantitative":[369],"measure":[370],"attention":[373],"that":[374],"research":[376],"has":[378],"received":[379],"online.":[380],"Clicking":[381],"on":[382,410],"donut":[384],"icon":[385],"will":[386],"load":[387],"page":[389],"at":[390],"altmetric.com":[391],"with":[392,427],"additional":[393],"details":[394],"score":[397,418],"social":[400],"media":[401],"presence":[402],"for":[403],"given":[405],"article.":[406],"how":[416],"calculated.":[420],"Share":[421,436],"Add":[422],"toView":[423],"InAdd":[424],"Full":[425],"Text":[426],"ReferenceAdd":[428],"Description":[429],"ExportRISCitationCitation":[430],"abstractCitation":[432],"referencesMore":[434],"Options":[435],"onFacebookTwitterWechatLinked":[437],"InRedditEmail":[438],"Other":[439],"access":[440],"optionsGet":[441],"e-Alertsclose":[442],"SUBJECTS:Alcohols,Amides,Catalysts,Organic":[443],"compounds,Solvents":[444],"Get":[445],"e-Alerts":[446]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2022-05-12T00:00:00"}